| Langelier, M.F.; Pascal, J.M. (2025). Human PARP1 ART domain bound to NAD+ analog benzamide adenine dinucleotide and ADP-ribose. Protein Data Bank: 9dmc. |
CMCF-BM |
PDB Deposition |
Health |
| Langelier, M.F.; Pascal, J.M. (2025). Human PARP1 ART domain bound to NAD+ analogs benzamide adenine dinucleotide and carba-NAD+. Protein Data Bank: 9bpy. |
CMCF-BM |
PDB Deposition |
Health |
| Lai, C.H.R.; Shah, M.; Nguyen, Q.H.; Moraes, T.F. (2025). Crystal structure of a Slam-dependent surface lipoprotein, PmSLP, in Pasteurella multocida. Protein Data Bank: 9b3e. |
CMCF-BM |
PDB Deposition |
Health |
| Krishnan, Shreya S; Shen, Yao; O’Hagan, Treasa B; Matthews, Lindsay A; Weerasinghe, Nuwani W et al. (2025). Asymmetric loading of TnsE regulates Tn7 targeting of DNA replication structures. Nucleic Acids Research 53(11) . 10.1093/nar/gkaf472. |
CMCF-BM |
Peer-Reviewed Article |
Health |
| Kinzel, Olaf; Goldberg, Steven D.; Cummings, Maxwell D.; Gege, Christian; Steeneck, Christoph et al. (2025). Identification of JNJ-61803534, a RORγt Inverse Agonist for the Treatment of Psoriasis. Journal of Medicinal Chemistry 68(8) , 8713-8728. 10.1021/acs.jmedchem.5c00390. [PDB: 9n9l] |
CMCF-ID |
Peer-Reviewed Article |
Health |
| Kin S. YANG; Hang CHU; Solomon H. REISBERG; Wai Yan CHOY; Brian P. BESTVATER et al. (2025). Reversible lysine covalent modifiers of cdk2 and uses thereof. Patent Number: WO2025090658. |
CMCF-ID |
Patent |
Health |
| Kimani, S.; Dong, A.; Hoffmann, L.; Nemec, V.; Ackloo, S. et al. (2025). Crystal structure of the human WDR5 in complex with LH168 compound. Protein Data Bank: 9d5z. |
CMCF-BM |
PDB Deposition |
Health |
| Khassan, Oleg (2025). Unraveling the Regulation of Plant and Yeast Plastin Proteins: A Structural Determination Study. Supervisor: Haji-Ghassemi, Omid. Alberter, Canada: University of Calgary. https://hdl.handle.net/1880/120616. |
CMCF |
Masters Thesis |
Health |
| Kaduk, James; Dosen, Anja; Blanton, Tom (2025). Crystal structure of anisomycin, C
14
H
19
NO
4
. Powder Diffraction , 1-6. 10.1017/s0885715625100791. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
| Kaduk, James A.; Dosen, Anja; Blanton, Tom N. (2025). Powder pattern and hydrogen bonding in the crystal structure of phenelzine sulfate, C
8
H
14
N
2
(SO
4
). Powder Diffraction , 1-5. 10.1017/s0885715625000545. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
| Kaduk, James A.; Dosen, Anja; Blanton, Tom N. (2025). Crystal structure of niraparib tosylate monohydrate Form I, (C
19
H
21
N
4
O)(C
7
H
7
O
3
S)(H
2
O). Powder Diffraction , 1-9. 10.1017/s0885715625000181. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
| Kaduk, James A.; Dosen, Anja; Blanton, Tom N. (2025). Crystal structure of ethynodiol diacetate, C
24
H
32
O
4
. Powder Diffraction , 1-6. 10.1017/s0885715625100729. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
| Kaduk, James A.; Dosen, Anja; Blanton, Tom N. (2025). Crystal structure of trametinib dimethyl sulfoxide, C26H23FIN5O4(C2H6OS). Powder Diffraction 40(2) , 162-167. 10.1017/s0885715625000168. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
| Kaduk, James A.; Dosen, Anja; Blanton, Tom N. (2025). Crystal structure of aprocitentan Form A, C16H14Br2N6O4S. Powder Diffraction 40(2) , 168-174. 10.1017/s088571562500017x. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
| Kaduk, James A.; Dosen, Anja; Blanton, Tom (2025). Crystal structure of repotrectinib, C18H18FN5O2. Powder Diffraction , 1-6. 10.1017/s0885715625100882. |
BXDS-WLE |
Peer-Reviewed Article |
Health |